oligo conjugates

Vida Ventures co-leads Dyne's $115M megaround for next-gen oligo therapies aimed squarely at muscles
Endpoints
Mon, 08/10/20 - 10:56 am
Dyne Therapeutics
oligo conjugates
Lilly pays $35M up front to partner with Avidity on oligo conjugates
BioCentury
Mon, 04/22/19 - 10:24 am
Eli Lilly
Avidity
oligo conjugates